· Published by Health Canada · Official notice
With the United States Food and Drug Administration (FDA) deciding to change dosage requirements for prescription acetaminophen combination products, Health Canada is updating Canadians on steps it is taking to determine if any new action may be needed to protect health and safety in addition to the recent updating of its acetaminophen labelling standard.
Prescription and non-prescription acetaminophen-containing products have a long history of treating pain and fever. When used as directed, they are considered to be both safe and effective.
Concerns have been raised, however, by reports of acetaminophen overdose resulting in serious and sometimes fatal liver damage.
In September 2009, Health Canada finalized a new labelling standard for non-prescription products containing acetaminophen. This labelling standard contains warning of potential serious and possibly fatal liver damage in the event of an overdose.
Health Canada continues to review emerging and available safety evidence, including that used by the FDA to reach its decision and will determine if any new action may be needed to protect health and safety.
In addition, there are a number of steps everyone should follow to take medication(s) safely: